Monopar Therapeutics (MNPR) Long-Term Investments (2022 - 2025)

Quarterly results put Long-Term Investments at $78.6 million for Q4 2025, up 445.75% from a year ago — trailing twelve months through Dec 2025 was $78.6 million (up 445.75% YoY), and the annual figure for FY2025 was $78.6 million, up 445.75%.

Monopar Therapeutics has reported Long-Term Investments over the past 4 years, most recently at $78.6 million for Q4 2025.

  • Long-Term Investments reached $78.6 million in Q4 2025 per MNPR's latest filing, up from $16.0 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $78.6 million in Q4 2025 and bottomed at $985730.0 in Q1 2024.
  • Median Long-Term Investments over the past 4 years was $6.0 million (2023), compared with a mean of $14.2 million.
  • The largest annual shift saw Long-Term Investments tumbled 83.43% in 2024 before it soared 1405.61% in 2025.
  • Over 4 years, Long-Term Investments stood at $4.9 million in 2022, then crashed by 39.61% to $3.0 million in 2023, then soared by 383.17% to $14.4 million in 2024, then surged by 445.75% to $78.6 million in 2025.
  • Business Quant data shows Long-Term Investments for MNPR at $78.6 million in Q4 2025, $16.0 million in Q3 2025, and $13.7 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 505,194.89
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 5.75 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 9.79 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 22.17 Mn
10 Monopar Therapeutics 466.82 Mn 466.82 Mn - 78.57 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 78.57 Mn
Sep 30, 2025 16.00 Mn
Jun 30, 2025 13.75 Mn
Mar 31, 2025 14.84 Mn
Dec 31, 2024 14.40 Mn
Jun 30, 2024 998,840.00
Mar 31, 2024 985,730.00
Sep 30, 2023 2.98 Mn
Jun 30, 2023 2.98 Mn
Mar 31, 2023 5.95 Mn
Dec 31, 2022 4.93 Mn